Evans WK, Gauvreau C, Flanagan W, et al. Costs and Cost-Effectiveness of Smoking Cessation Within an Organized CT Lung Cancer (LC) Screening Program. 18th World Conference on Lung Cancer (WCLC) 2017, abstract OA 06.01.
Apixaban niet inferieur aan dalteparine bij kankergeassocieerde VTE
jun 2020 | Benigne hematologie